The FDA has cleared Hardy Diagnostics’ NG-TEST CTX-M Multi, a visual, in vitro,  immunoassay that detects resistance-related enzymes in bacteria. The test identifies CTX-M enzymes — specifically groups 1, 2, 8, 9 and 25 — from pure colonies of Enterobacterales that may be producing extended-spectrum β-lactamases (ESBLs). Enterobacterales, which include Escherichia coli (E.coli) and Klebsiella […]